Acelyrin
Acelyrin is a biopharmaceutical company focused on acquiring and developing innovative immunology therapies, with a lead candidate for inflammatory diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $300M
About
Acelyrin is a biopharmaceutical company focused on acquiring and developing innovative immunology therapies, with a lead candidate for inflammatory diseases.
ImmunologyBiologics
Funding History
1Total raised:$300M
Venture$300M